DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology

0
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...

Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.

0
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....

Popular News

The FDA Accepts Investigational New Drug (IND) Application for a Phase...

0
Capricor Therapeutics Inc. (NASDAQ:CAPR) is one of the companies fully involved in investigating exosome science. The company's exosome technology is reportedly active in several...

MAKE IT MODERN

LATEST REVIEWS

Iterum Therapeutics plc (NASDAQ:ITRM) Submits New Drug Application For Oral Sulopenem...

0
Iterum Therapeutics plc (NASDAQ:ITRM) has announced the submission of a New Drug Application to the US FDA for sulopenem etzadroxil/probenecid. The application is for...

MAKE IT MODERN

PERFORMANCE TRAINING

Abeona Therapeutics Inc (NASDAQ: ABEO) Reports Positive Data Of Its Ongoing Clinical Trials Of...

0
Abeona Therapeutics Inc (NASDAQ:ABEO) reported new interim positive data from its Phase 1/2 ongoing clinical studies of ABO-101 and ABO-102 in MPS IIIB and...

Progenity Inc. (NASDAQ: PROG) Receives Single-Molecule Detection Platform Patent From USPTO

0
Progenity Inc. (NASDAQ: PROG) has announced a new patent associated with a single-molecule detection platform currently under development. The patent covers single target nucleic acid...
HFT

Mid Day Market Update – January Effect

0
Markets are playing a little fakeout today with some decent action in the major indexes. The IWM is down 0.5%, while the...

Dynavax Technologies Corporation (NASDAQ:DVAX) Completes Enrolment IN Study Evaluating Hepatitis B Vaccine, HEPLISAV-B

0
Dynavax Technologies Corporation (NASDAQ:DVAX) has announced the completion of registration of 119 patients in its clinical study evaluating its Hepatitis B vaccine HEPLISAV-B in...

Oragenics, Inc (NYSE:OGEN) Inks A Pact With Biodextris Inc To Use Three IMAs...

0
Oragenics, Inc (NYSE:OGEN) entered an accord with Biodextris Inc in March 2021. As per the terms of the pact, Oragenics will use three IMAs...

MAKE IT MODERN

POPULAR

romabet mahbet پین باهیس bettingmagazine.org بت کارت یاس بت yekbet megapari onjabet alvinbet betboro betfa بت فوروارد 1xbet 1win betwinner 4shart.com 1xbetgiris.cam وان کیک بت وین بت ریتزوبت 1xbet-ir.com.co وان ایکس بت بت فوروارد